US HB1613 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 17 2023 - 25% progression
Action: 2023-03-17 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 17 2023 - 25% progression
Action: 2023-03-17 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.
Title
Drug Price Transparency in Medicaid Act of 2023
Sponsors
| Rep. Earl Carter [R-GA] | Rep. Vicente Gonzalez [D-TX] | Rep. Elise Stefanik [R-NY] | Rep. Deborah Ross [D-NC] |
| Rep. Rick Allen [R-GA] | Rep. Jake Auchincloss [D-MA] | Rep. Cory Mills [R-FL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-03-17 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-03-17 | House | Introduced in House |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/1613/all-info |
| Text | https://www.congress.gov/118/bills/hr1613/BILLS-118hr1613ih.pdf |
